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OPINION
Risk factors for vascular dementia: Hypotension 
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Abstract: Physiologically, the cerebral autoregulation system allows maintenance of constant 
cerebral blood ﬂ  ow over a wide range of blood pressure. In old people, there is a progressive 
reshape of cerebral autoregulation from a sigmoid curve to a straight line. This implies that any 
abrupt change in blood pressure will result in a rapid and signiﬁ  cant change in cerebral blood 
ﬂ  ow. Hypertension has often been observed to be a risk factor for vascular dementia (VaD) and 
sometimes for Alzheimer disease although not always. Indeed, high blood pressure may accel-
erate cerebral white matter lesions, but white matter lesions have been found to be facilitated 
by excessive fall in blood pressure, including orthostatic dysregulation and postprandial hypo-
tension. Many recent studies observed among other data, that there was a correlation between 
systolic pressure reduction and cognitive decline in women, which was not accounted for by 
other factors. Baseline blood pressure level was not signiﬁ  cantly related to cognitive decline 
with initial good cognition. Some researchers speculate that blood pressure reduction might be 
an early change of the dementing process. The most confounding factor is that low pressure by 
itself might be a predictor of death; nevertheless, the effect of low blood pressure on cognition 
is underestimated because of a survival bias. Another explanation is that clinically unrecognized 
vascular lesions in the brain or atherosclerosis are responsible for both cognitive decline and 
blood pressure reduction. We discuss the entire process, and try to deﬁ  ne a possible mechanism 
that is able to explain the dynamic by which hypotension might be related to dementia.
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As longevity increases worldwide, age-related dementias are burgeoning. Age-related 
cerebral degenerative changes are coupled therefore with decreased perfusion, usually 
assumed to be secondary to decreased cerebral metabolic demands (Meyer et al 1999). 
During aging, the declines in cerebral tissue densities of the gray cortex (polio-araiosis) 
and of the white matter (leuko-araiosis) reﬂ  ect neuronal degenerative changes, which 
progress concurrently with cerebral perfusion declines.
In particular, leuko-araiosis correlates with advancing age, cerebral atrophy, hypo-
perfusion of white matter, and cognitive impairments (Meyer et al 2000). Leuko-araiosis 
is detectable in 9%–19% of older ‘normal’ subjects, but is virtually always present in 
vascular dementia (VaD). Of special interest are the data emerging from the study of 
Meyer and colleagues (2000): normative subjects destined for later cognitive decline 
had excessive leuko-araiosis at study entry, suggesting leuko-araiosis is, by itself, a 
risk factor for cognitive decline.
Thus, the researchers are trying to deﬁ  ne the passage between normality, the 
so-called leuko-araiosis age-related and the excess of the response to the vascular 
damage, conﬁ  guring the dementia, as a clinical syndrome. White matter injury 
may lead to brain atrophy or disrupted cholinergic ﬁ  bers, but this relation has been 
incompletely studied. Interestingly, the independent role of asymptomatic lacunar Vascular Health and Risk Management 2008:4(2) 396
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infarcts is less clear, with the possible exception of those 
involving the thalamus. Sensitive and speciﬁ  c deﬁ  nitions 
of cerebrovascular cognitive impairment are hampered by 
the fact that cerebrovascular disease is not easily linked to 
cognitive syndromes, either clinically or pathologically, and 
the presence of coincident Alzheimer disease (AD) is com-
mon. Moreover, it is clear that some individuals may have 
a slowly progressive, dementing illness caused exclusively 
by cerebrovascular disease. Some individuals presenting 
cerebrovascular pathology probably have some component 
of AD pathology as part of their dementia; this relationship 
supports the possible interaction between cerebrovascular 
disease, aging, and the degenerative process.
The literature supports the concept that VaD refers to a 
broad category of patients, where a multi-faceted cognitive 
decline is attributed to cerebrovascular disease. It has long 
been known that cognitive deﬁ  cits may result from a stroke; 
yet, only recently, have reports demonstrated that dementia 
may occurs in approximately one-fourth to one-third of stroke 
cases (Tatemichi et al 1992).
Treatment of vascular cognitive impairment may need to 
emphasize primary or secondary prevention of vascular risk 
factors such as hypertension, but some symptomatic treat-
ments are beginning to show modest success.
It should be considered that VaD is not a univocal and 
unique pathology, and, therefore, even the concept of vascular 
risk factor should not be schematic, univalent, or used as a 
single-track way.
Vascular dementia
The National Institute of Neurological Disorders and Stroke 
and the Association Internationale pour la Recherche et al’ 
Enseignement en Neurosciences (NINDS-AIREN) (Roman 
et al 1993) provided a clinical and diagnostic tool, the so-
called NINDS-AIREN criterion. It lists different pathologies, 
in order to identify patients with different subtypes of VaD: 
multi-infarct dementia (multiple large and complete infarcts), 
post-hemorrhage dementia, and subcortical VaD (small-
vessel disease). According to NINDS-AIREN, the subcortical 
VaD (sVaD) is mainly due to lacunar infarct, occurring in 
distribution of small arterioles, usually in the white matter, 
basal ganglia, thalamus and pons, or to microinfarct – not 
seen on macroscopic examination – a small area of cystic 
or noncystic necrosis surrounded by astrocytes. Incomplete 
infarct may also be present, due to a selective loss of neurons, 
myelin, and oligodendrocytes, without cystic necrosis, occur-
ring in the periphery of major artery distribution infarcts 
(eg, penumbra) or in deep white matter. Incomplete white 
matter infarcts are associated with myelin pallor, astrocytosis, 
and a variable degree of axonal loss. Subcortical VaD 
now incorporates the old entities of ‘lacunar state’ and 
‘Binswanger’s disease’, and it relates to small vessel disease 
and hypoperfusion, resulting in focal and diffuse ischaemic 
white matter lesions and incomplete ischaemic injury 
(Erkinjuntti 1997; Pantoni et al 2000).
Small vessel dementia (sVAD) is presumably the most 
frequently pathological condition observed in elderly patients 
(Akiguchi et al 1997). sVAD is due to infarcts caused by 
obstruction of intracerebral vessels of arteriolar size, subcor-
tically represented by the long penetrant arteries. The cause 
may be micro-emboli from heart valves or atheromatous large 
vessel lesions, particularly carotid stenosis or special vessel 
diseases such as collagen or inﬂ  ammatory diseases (Lishman 
1997), amyloid angiopathy (especially the hemorrhagic 
familial forms), and other hereditary angiopathies.
The major known causative factor of  VaD is hypertensive 
angiopathy. It may assume two forms: cortical plus subcor-
tical, and purely subcortical, referred to as Binswanger’s 
disease or progressive subcortical vascular encephalopathy. 
The lacunar state may be regarded as a milder form of the 
latter. The two varieties are basically similar, showing mostly 
small infarcts of lacunar size up to 10 to 15 mm in diameter 
(Brun 2004).
Binswanger’s disease is marked by lacunar infarcts usu-
ally measuring 5–10 mm in diameter and situated in the brain 
stem and central gray nuclei but above all in the frontal white 
matter, sparing the cortex and u-ﬁ  bers. In the white matter the 
lacunes are surrounded by wide areas of incomplete infarcts 
with partial loss of axons, myelin and oligodendroglial cells 
accompanied by a mild astrocytic gliosis causing an exten-
sive cortical undermining and disconnection. This change 
impresses as the main structural substrate for the functional 
deﬁ  cit in Binswanger’s disease, explaining, for example, 
frontal symptoms, gait, and incontinence problems. The small 
lacunes are probably of lesser importance. The loss of white 
matter is reﬂ  ected in a widening of especially the frontal 
ventricular horns. Portions of less severe incomplete white 
matter infarcts may not be demonstrable on brain imaging, 
causing clinical-pathological correlation difﬁ  culties (Brun 
1994; Englund 2000, 2004).
Risk factors: Blood pressure
There is an overlap of risk factors between VaD and AD, so 
much so that it raises some serious questions about vascu-
lar contributions to AD. Recognition that cerebrovascular 
disease causing dementia may be modiﬁ  ed by treatment Vascular Health and Risk Management 2008:4(2) 397
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of cerebrovascular risk factors serves as an important tool 
for investigating various treatments aimed at secondary 
prevention of vascular cognitive impairment (Brookmeyer 
et al 1998).
Hypertension has often been observed to be a risk fac-
tor for VaD (Hebert et al 2000; Posner et al 2002; Skoog 
and Gustafson 2002) and sometimes for AD (Prince et al 
1994; Launer et al 1995; Hofman et al 1997) although not 
always (Morris et al 2001). Hypertension leads to changes in 
arterioles and eventually to arteriolar occlusive disease and 
then on to infarction. Hypertension’s effects on the brain in 
VaD or AD could also be related to changes in blood ﬂ  ow or 
blood-brain-barrier integrity. A large number of epidemio-
logical studies show strong associations between elevations 
in middle-life blood pressure and the prevalence of later life 
cognitive impairment and dementia. Early evidence suggest 
that treatment hypertension in the elderly may be quite suc-
cessful in reducing incident dementia. In the Syst-Eur trial 
(Forette et al 1998), cognition was primarily assessed by the 
Mini-Mental State Examination. Treatment with a calcium 
channel blocking antihypertensive was associated with a 
nearly 50% reduction in incident dementia amongst approxi-
mately 2000 elderly with isolated systolic hypertension. The 
conclusions of this study, given the high percentage of elderly 
suffering with untreated hypertension, are that secondary 
prevention treatment trials such as Syst-Eur might have a 
substantial impact on cognitive impairment.
The relation between hypertension, its treatment, and 
severe white matter lesions has been assessed in 10 European 
cohorts (van Dijck et al 2004). White matter lesions in the 
periventricular and subcortical regions were rated separately 
using semiquantitative measures. Increase in systolic blood 
pressure levels were associated with more severe periven-
tricular and subcortical white matter lesions. People with 
poorly controlled hypertension had a higher risk of severe 
white matter lesions than those without hypertension (van 
Dijck et al 2004).
Recent works, on the contrary, underline a potential nega-
tive effect by decreasing diastolic blood pressure level on the 
occurrence of severe periventricular white matter lesions.
A high pulse pressure is related to arterial stiffness, which 
might be considered one of its clinical indicator, and it is 
associated with an increased risk of dementia (Qiu et al 2003). 
Therefore, it could be postulated that functional changes 
of the arterial system are involved in the pathogenesis of 
dementia (Volpe and Scuteri In Press). Two cross-sectional 
studies have shown a positive correlation between arterial 
stiffness and cognitive impairment in subjects with nonvascular 
(Nagai et al 2004) or vascular (Mizushima et al 2003) dementia. 
In a recent cross-sectional study, it has been demonstrated 
that arterial stiffness was associated with a lower cognitive 
performance independently of traditional cardiovascular risk 
factors (Hanon et al 2005; Scuteri et al 2005, 2007). A very 
recent study (Protogerou et al 2007) showed that, in the frail 
elderly, a value of diastolic blood pressure inferior of 60 mmHg, 
is associated with radical decrease of survival, independent from 
large artery stiffness and left ventricular function, suggesting 
that more rational antihypertensive therapy, not only based on 
systolic pressure level is needed.
An increased arterial stiffness (Scuteri 2007) tends to 
annul the proper cushion of the walls, the so-called Windkessel 
effect. The cerebral high resting blood ﬂ  ow implies that 
vessels are more dilated than in other vascular beds; therefore 
pulsations may extend more deeply towards the smallest 
vessels (Nichols et al 2005; O’Rourke and Safar 2005). 
Increased arterial stiffness is responsible for a disproportionate 
increase in systolic blood pressure and a relative decrease in 
diastolic pressure; thus, the consequent higher pulse pressure 
at any given value of mean blood pressure is likely to cause 
macrovascular damage (Laurent et al 2003) and microvascular 
disruption (Nichols et al 2005). Physiologically, cerebral 
autoregulation allows maintenance of constant cerebral blood 
ﬂ  ow over a wide range of blood pressure (approximately 
80 to 200 mmHg). With aging, there is a progressive reshape 
of cerebral autoregulation from a sigmoid curve to a straight 
line. This implies that any abrupt change in blood pressure 
will result in a rapid and signiﬁ  cant change in cerebral blood 
ﬂ  ow (Moretti et al 2006; Volpe and Scuteri In Press).Since 
stiffer arterial system implies reduced arterial cushioning 
function, any hemodynamic changes will result in an 
exaggerated change in blood pressure levels, and high blood 
pressure levels are as dangerous as low blood pressure levels 
in older hypertensive subjects (Volpe and Scuteri In Press). 
Indeed, high blood pressure may accelerate cerebral white 
matter lesions (Yamamoto et al 1998; Schmidt et al 1999), 
but white matter lesions have been found to be facilitated 
also by excessive fall in blood pressure (Nakamura et al 1995; 
Kario et al 1996; Watanabe et al 1996; Chamorro et al 1997), 
including orthostatic dysregulation (Matsubayashi et al 1997) 
and postprandial hypotension (Kohara et al 1999).
Hypotension and dementia
The traditional general practice teaches that “the lower the 
blood pressure is, the better the prognosis”. Albeit this, low 
blood pressure as a predictor of increased mortality has 
been described in a 5-year prospective study in Finland Vascular Health and Risk Management 2008:4(2) 398
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(Mattila et al 1988) as well as paradoxical survival of elderly 
men with high blood pressure (Langer et al 1989).
Interpretations of these so-called J-shaped curves between 
blood pressure, and mortality have always been viewed with 
caution and skepticism by epidemiologists and statisticians 
(Fletcher and Bulpitt 1992; Glynn et al 1995). There are many 
medical situations (diabetes, cardiac damage, hyposurreal-
ism, and idiopathic) where hypotension is a dominant aspect. 
Many epidemiological studies conﬁ  rm that chronic low 
blood pressure does not by itself imply increased cardiovas-
cular risk after adjustment for possible confounding factors. 
Chronic low blood pressure has been positively associated 
with a number of clinical symptoms and psychosomatic 
distress – including unexplained fatigue, depression, and 
anxiety – and with minor psychiatric morbidity (De Buyzere 
et al 1998). A causal relationship between low blood pressure 
and low mood remains uncertain, but a vicious circle should 
not be excluded (De Buyzere et al 1998). Zhu and colleagues 
(1998) tried to deﬁ  ne the potential role of blood pressure in 
cognition. In a community cohort of 924 persons aged 75 
years with initially good cognition, they observed that there 
was a correlation between systolic pressure reduction and 
cognitive decline in women, which was not accounted for by 
other factors. Baseline blood pressure level was not signiﬁ  -
cantly related to cognitive decline in that sample with initial 
good cognition. Zhu and colleagues (1998) also speculated 
that blood pressure reduction might be an early change of the 
dementing process (see also literature in Gorelick 1997).
Ruitenberg and colleagues (2001) found that lower sys-
tolic and diastolic blood pressures at baseline were associated 
with a higher risk of dementia at follow-up. This association 
was observed across all age strata, in men as well in woman 
and both in AD and VaD. The authors observed a larger 
decrease in blood pressure in all age categories of prevalent 
dementia patients compared with subjects without demen-
tia. Subjects with incident dementia also decreased more in 
blood pressure level than in persons without dementia. This 
difference was not statistically signiﬁ  cant (Ruitenberg et al 
2001). This may reﬂ  ect that low blood pressure causes or 
contributes to dementia or that incipient dementia leads a 
drop in blood pressure (Ruitenberg et al 2001). Ruitenberg 
and colleagues (2001) suggested that for the ﬁ  rst part of the 
proposition, they observed an inverse association between 
blood pressure and dementia mainly in subjects, who used 
antihypertensive medication. This may indicate that their 
hypertension was longer lasting, and perhaps that these 
patients were more susceptible to pressure drops, causing 
inadequate cerebral blood ﬂ  ow. That would be particularly 
important in vulnerable areas, such as watershed zones and 
white matter. A second explanation given by Ruitenberg and 
colleagues (2001) was that low pressure might be a conse-
quence of an incipient dementia. It was found that blood 
pressure was lower in subjects with manifest dementia, and 
those with dementia, who presented lower pressure, declined 
more rapidly. The possible explanation given by Ruitenberg 
and colleagues (2001) is that several areas are involved in 
pressure regulation; Burke and colleagues (1994) reported 
a strong correlation between the decrease of the number of 
C1 neurones in the medulla oblongata and blood pressure 
dysregulation in Alzheimer patients.
More recently, Guo and colleagues (1999) tried to exam-
ine whether initially low blood pressure is related to the inci-
dence of dementia in a sample of 304 persons, aged 75 to 96 
years. The ﬁ  ndings showed that compared with individuals 
with baseline systolic pressure of 140 to 179 mm Hg, those 
with systolic pressure of 140 mmHg or less had a signiﬁ  cantly 
higher risk of dementia and AD. That was the ﬁ  rst study to 
clearly report an association between relatively low systolic 
pressure and increased incidence of dementia. Relatively low 
blood pressure seems to be correlated with dementia even in a 
preclinical stage. Guo and colleagues (1999) started from the 
speculation that cerebral blood ﬂ  ow is reduced in dementia 
patients (Brown and Frackowiak 1991). That was generally 
thought to be related with reduced metabolic activity of the 
brain or with a major vascular lesion. The authors hypoth-
esized that the reduction of cerebral blood ﬂ  ow might be 
related to the impairment of the cerebral autoregulation, sec-
ondary to the degenerative disorder. The direct consequence 
would be a sequential ulterior reduction of blood pressure, 
due to dysregulation, which might accelerate the lowering 
of blood perfusion and therefore the underlying degenerative 
process (Guo et al 1996; Bolster et al 2001; Yamamoto et al 
2001; Mehagnoul-Schipper et al 2002; Nilsson et al 2007). 
Lower systolic blood pressure was associated with cognitive 
decline and dementia. Earlier history of arterial hypertension 
was related to an increased risk of impaired cognition and 
dementia. Nilsson and colleagues (2007) interpreted these 
results as a potential expression of the frailty and deterio-
rated vitality of the oldest elderly, in keeping constantly the 
autoregulation capabilities of the normal brain, and expressed 
their concern, due to this frailty, on the real impact of lower-
ing pressure in oldest age.
Our impression
The reason is unknown, but frontal lobes have a metabolism 
rate under basal condition that is 20% more than that of the Vascular Health and Risk Management 2008:4(2) 399
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other brain areas (Moretti et al 2006). And it is also well 
known that age-related cognitive modiﬁ  cations are related to 
frontal dysfunctions (Levine et al 1997; Esposito et al 1999; 
Kramer et al 1999), due to a reduction of brain reserve capac-
ity. This brings an aged individual closer to the level of insuf-
ﬁ  ciency where only minor additional lesions may be required 
to precipitate dementia. The degenerative aging changes, 
though milder, repeat much of the pathology of AD.
In VaD, especially in subcortical vascular type, there 
is an accentuated expression of what is found in old age 
(Moretti et al 2006). The importance of aging in this context 
is emphasized by the ﬁ  nding that VaD is the most common 
form of organic dementia after the age of 85. The complete 
and incomplete white matter infarction, frequently coexisting, 
would, by virtue of their high prevalence, be the underlying 
substrate in the recognition of white matter disease (de Reuck 
2000), leukoencephalopathy, or leukoaraiosis (Hachinski 
1994).
The vessels show a degeneration of the smooth muscle 
layer, which is replaced by collagen in a hyaline ﬁ  brosis, 
leading to a subtotal luminal occlusion. These arterioles 
share traits with nonhypertensive lipohyalinosis (Zhang 
et al 1994), as well as with hypertensive arteriolosclerosis, 
and may concur with hypertensive changes. Anatomically, 
the smaller resistance blood vessels undergo degenerative 
changes consisting of thickening and ﬁ  brosis of the media 
(in muscular arteries) and intima, and patchy degeneration 
of smooth muscle cells producing luminal narrowing and 
increased vascular resistance. Although the resting CBF is 
the same in normotensive and hypertensive individuals, these 
structural changes limit the capacity of the resistance vessels 
for maximal vasodilatation and impair tolerance of lower 
blood pressures, while improving tolerance to hypertension 
through vasoconstriction of these same vessels. Long-term 
antihypertensive treatment can reverse these adaptive changes 
and shift the autoregulation curve back to its normal range, 
although only limited reversibility occurs in elderly hyper-
tensive patients.
A primary hemodynamic etiology of vascular dementia 
concerns the cerebral hypoperfusion that affects either the 
whole brain, the deep central white matter or speciﬁ  c regions 
that are more susceptible to damage due to focal vascular 
pathology.
The most common cause of hemodynamic disturbances 
with a drop in blood pressure is that of cardiovascular fail-
ure (Salloway 2003). Cardiac disease and cardiovascular 
failure contribute considerably to the development of VaD 
(Salloway 2003), not only through cardiac embolism but 
also from the effects of hemodynamic insufﬁ  ciency. The 
effects of arrhythmia here will be a cerebral, notably episodic 
hypoperfusion, extended far along the penetrating arterioles 
and resulting in deep white matter damage (Salloway 2003). 
Secondary causes of hypoperfusion are dysautonomias, 
which constitute the set of disease states in which an abnor-
mality of the autonomic nervous system (ANS) is critical to 
the pathogenesis. An age-related impairment of the vascular 
autoregulation due to impaired functioning of the autonomic 
nervous system can lead to symptom-producing blood pres-
sure lability in the elderly. Additionally, age-related arteriolar 
changes, including endothelial changes, have been suggested 
to reduce the baroreﬂ  ex activity and thereby predispose 
for deleterious blood pressure falls (Salloway 2003). The 
prevalence of orthostatic and nonorthostatic hypotension 
reached 50% in clinically evaluated VaD cases (Salloway 
2003; Mirski 2005).
The possible reason that relates lower blood pressure, 
dysregulation of cerebral blood ﬂ  ow and vascular dementia, 
is the pivotal role of acetylcholine (ACh). ACh regulates the 
cerebral blood ﬂ  ow through the parasympathetic innervation 
of the circle of Willis and of the pial vessels (Vasquez and 
Purve 1979), and it causes signiﬁ  cant arterial relaxation by 
promoting the synthesis of vasodilator agents (Vanhoutte 
1989).
Preclinical research using the spontaneously hyperten-
sive stroke-prone rat model of VaD has shown a signiﬁ  cant 
reduction in the levels of ACh and choline in the cortex, hip-
pocampus, and cerebrospinal ﬂ  uid compared with normal rats 
(Kimura et al 2000). When compared with normal rats, spon-
taneously hypertensive stroke-prone rats have signiﬁ  cantly 
lower levels of acetylcholine in the cerebrospinal ﬂ  uid (CSF) 
(Togashi et al 1994). In the latter study, the differences in CSF 
levels between normal rats and stroke prone rats increased 
with age, suggesting progressive deterioration of central 
cholinergic function in hypertensive stroke prone rats.
The cholinesterase inhibitor epistigmine has been shown 
to improve blood ﬂ  ow in the Sprague-Dawley rat with tan-
dem occlusion of left middle cerebral and common carotid 
arteries. Epistigmine also enhanced the ischemia-induced 
rostral shift of cerebral blood ﬂ  ow maximum in the contra-
lateral hemisphere and the redistribution of cerebral blood 
ﬂ  ow, a phenomenon possibly related to recovery of function 
(Scremin et al 1997).
As with other types of dementia, the pathological 
changes observed in patients with VaD appear to be associ-
ated with cholinergic deﬁ  cits. Compared with normal rats, 
rat models of VaD have shown signiﬁ  cantly reduced levels Vascular Health and Risk Management 2008:4(2) 400
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of the neurotransmitters ACh and choline in the cortex and 
hippocampus (Togashi et al 1996), which appear to correlate 
with impaired learning and memory (Togashi et al 1996).
In humans, post-mortem studies have shown that cho-
line acetyltransferase (ChAT) activity is reduced in VaD 
patients, compared with controls (Wallin et al 1989). Fur-
thermore, clinical studies have indicated that patients with 
subcortical VaD have signiﬁ  cantly lower concentrations 
of ACh in the cerebrospinal ﬂ  uid, and that these decreases 
are strongly correlated with cognitive deﬁ  cits (Wallin et al 
1989). The number of muscarinic cholinergic receptors is 
also markedly reduced in VaD and mixed dementia patients 
(Sakurada et al 1990). In addition, the level of ACh in the 
cerebral ﬂ  uid of VaD patients is signiﬁ  cantly lower than in 
controls, but is similar to the level observed in AD patients 
(Szilagy et al 1987).
Very recently, to prove the role of ACh in vessal regula-
tion muscarinic receptors, M5, have been studied. The M5 
muscarinic receptor is the most recent member of the mus-
carinic acetylcholine receptor family (M1-M5) to be cloned. 
Because M5 receptor mRNA has been detected in several 
blood vessels, Yamada and colleagues (2001) investigated 
whether the lack of M5 receptors led to changes in vascular 
tone by using several in vivo and in vitro vascular prepara-
tions in knockout mice. Strikingly, acetylcholine, a powerful 
dilator of most vascular beds, virtually lost the ability to dilate 
cerebral arteries and arterioles in M5R_/_ mice. This effect 
was speciﬁ  c for cerebral blood vessels, because acetylcho-
line-mediated dilation of extracerebral arteries remained fully 
intact in M5R_/_ mice.
Harrison and colleagues (2002) demonstrated that the 
intensity of the intrinsic signals generated from a brain acti-
vated region depends on local vascular density. Moreover, it 
has been demonstrated that the vascular dilatation responsible 
for the increase in blood ﬂ  ow evoked by neural activity is 
propagated in a retrograde fashion to upstream arterioles 
located outside the activated area (Iadecola et al 1997). 
This phenomenon termed retrograde vasodilation serves the 
purpose of dilating upstream arterioles that are critical for 
regional ﬂ  ow control.
Thus, it can be stated that:
1.  The cerebral blood ﬂ  ow is mainly regulated by arteri-
oles.
2.  The signal level of brain activation depends on the local 
vascular density, and mostly on their vasodilatation.
3.  In sVaD, arterioles smooth muscle layer is replaced by 
collagen in a hyaline ﬁ  brosis, leading to a subtotal luminal 
occlusion.
4.  ACh intimately regulates the cerebral blood ﬂ  ow through 
the parasympathetic innervation, and it causes signiﬁ  cant 
arterial relaxation by promoting the synthesis of vasodila-
tor agents.
5.  There is a macroscopic reduction of ACh in sVaD.
Therefore, it might be hypothesized that the damage of 
arteriole causes a reduction of cerebral blood ﬂ  ow. The other 
macroscopic consequence is the disruption of the cerebral 
autoregulation. The dysregulation is augmented by the reduc-
tion of ACh. These aspects might determine the sensitiveness 
of old patients, and especially demented patients, to hypoten-
sion. Each clinical condition that may lead to hypotension 
might accelerate the underlying degenerative process.
To determine if hypotension is a cause or a consequence 
of VaD, further studies will be necessary. The present review 
raises concern about a risk for the aging or the pathological 
brain from blood pressure lowering.
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